Abstract: A process is disclosed for purifying a hydrofluoropropane of undesirable C2–C4 olefinic and C1–C4 saturated chlorinated impurities, comprising the steps of: contacting a first mixture of hydrofluoropropane, olefinic impurity and saturated chlorinated impurity with hydrogen and hydrogen fluoride concurrently in the presence of a bifunctional catalyst, for example an alloy of gold and palladium supported on carbon, capable of catalyzing hydrogenation and fluorination. During the contacting step, olefinic impurity is converted to saturated hydrogenated derivative and/or saturated hydrofluorinated derivative, and saturated chlorinated impurity is converted to a saturated hydrodechlorinated derivative and/or saturated fluorinated derivative. The hydrofluoropropane thus formed is substantially free of both the olefinic and saturated chlorinated impurities and may be used as obtained or subject to further purification steps such as distillation to remove the process derivatives (e.g.

Abstract: The present invention provides a method for producing industrially useful fluorine-containing compounds such as a fluorinated ester compound and an acid fluoride compound. Namely, the present invention resides in a method for producing a fluorinated ester compound, which comprises fluorinating an ester compound which is an ester of a compound having hydroxyl group(s) with a compound having acyl fluoride group(s) and which has a structure which can be fluorinated, in a liquid phase to produce a fluorinated ester compound, wherein the fluorination is carried out in the form of a liquid mixture of the ester compound and the compound having acyl fluoride group(s).

Abstract: There is disclosed a method of producing ?,?-unsaturated carboxylic acid of formula (3) wherein R1 denotes a hydrogen atom, an alkyl group, an aryl group, an aralkyl group, an alkenyl group or an alkynyl group, which method comprises reacting a carboxylic acid of formula (1) wherein R1 denotes the same as the above, or carboxylic anhydride of formula (2) wherein R1 denotes the same as the above, with a methylenating agent in a presence of a catalyst containing metal of Group 13 of the Periodic Table of Elements in the amount of not more than 5 weight %.

Abstract: A process prepares an aqueous alkali metal acrylate solution by distillatively removing acrylic acid from a mixture as vapors and taking up the vapors immediately from the gas phase into an aqueous alkali solution.

Abstract: The present invention provides compounds which inhibit serine protease activity of matriptase or MTSP1. Also provided are pharmaceutical compositions comprising those compounds and methods of using the compounds and pharmaceutical compositions to treat conditions ameliorated by inhibition of matriptase or MTSP1.

Abstract: Chiral ligands and metal complexes based on such chiral ligands useful in asymmetric catalysis are disclosed. The metal complexes according to the present invention are useful as catalysts in asymmetric reactions, such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation, isomerization, cyclopropanation, Diels-Alder reaction, Heck reaction, isomerization, Aldol reaction, Michael addition; epoxidation, kinetic resolution and [m+n] cycloaddition. Processes for the preparation of the ligands are also described.

Abstract: The present invention relates to a care and/or make-up composition for the skin and/or lips of human beings, containing a liquid fatty phase comprising at least one anhydrous solvent, structured by a thermotropic liquid crystal polymer in order to obtain media having approximately the consistency of a gel at ambient temperature and that of a fluid when applied to the skin or lips of human beings.

Abstract: Methyl (R)-2-(R1OSO2)-2-(2-chlorophenyl)acetates useful as intermediates in the preparation of methyl (S)-2(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothieno[3,2-c]-5-pyridyl)acetate.

Abstract: The invention relates to novel substituted aryl ketones of the formula (I) in which Z, X, R and n are as defined in the disclosure, to processes for their preparation and to their use as crop treatment agents, and to intermediates for preparing compounds of the formula (I).

Abstract: Compounds of formula (I), wherein A is S or O; x is 0 or 1; a is SR10 or N(R11)(R12); R1 and R2 are C1–C24alkyl, OR10, CF3 or halogen; R3, R4 and R5 are hydrogen, C1–C24alkyl, OR10 or halogen; or two of the radicals R11 R21 R31 R4 and/or R9 together form C1–C2oalkylene uninterrupted or interrupted by O, S or NR13; R6, R11 R8 and R9 are hydrogen, C1–C24alkyl; C2–C24alkyl which is interrupted one or more times by non-consecutive O atoms and unsubstituted or substituted by OH and/or SH, or R6, R7, R8 and Rg are OR10; halogen; or phenyl unsubstituted or substituted one or more times by C-Calkyl; R10, R11 and R12 are e.g. hydrogen; X is e.g.

Abstract: The invention is directed to aromatic vinyl sulfide compounds of general formula A(—S—CH?CH2)z, wherein z is in the range of 1–4 and A represents highly halogenated and highly halogenated-deuterated phenyl, biphenyl and naphthalene compounds; highly halogenated and highly halogenated-deuterated biphenyl ethers and thioethers; and highly halogenated and highly halogenated-deuterated unsaturated 5- and 6-member heterocyclic ring systems containing carbon and at least one heteroatom selected from the group consisting of nitrogen, oxygen and sulfur. The aromatic vinyl sulfide compounds of the invention can be used to prepare elements and devices suitable for use in optical communications.

Abstract: The present invention is directed to phosphine ligands and the use of such ligands in catalytic complexes with transition metals. The catalysts may be used in a variety of reactions and are especially useful for refining halogenoaromatics.

Abstract: The present invention relates to a process for the preparation of monohydroperfluoroalkanes, bis(perfluoroalkyl)phosphinates and perfluoroalkylphosphonates which comprises at least the treatment of at least one perfluoroalkylphosphorane with at least one base in a suitable reaction medium.

Abstract: The invention relates to a process for preparing N-phosphono-methylglycine by reacting a hexahydrotriazine compound with a triacyl phosphite in an organic solvent, hydrolyzing the resulting phosphono compound after prior extraction into an aqueous phase and separation from the organic phase. The process avoids decomposition of the organic solvent during hydrolysis.

Abstract: The present invention provides the use of a fluorinated polyether composition as a surfactant, said fluorinated polyether composition comprising a mixture of fluorinated polyethers of the formula: (Rf)n—Xw—Z ??(I) wherein n is 1 or 2, w is 0 or 1, X is a divalent or trivalent organic linking group, Z is a polar group selected from the group consisting of an acid group or a salt thereof, an ammonium group, an amine-oxide group and an amphoteric group, and Rf represents a perfluorinated polyether group of the formula: CF3CF2CF2—O—[CF(CF3)CF2O]k—CF(CF3)— wherein k is at least 1; said mixture of fluorinated polyethers having a weight average molecular weight between 750 g/mol and 5000 g/mol and the amount of perfluorinated polyether groups in said mixture where k is 2 or less, is not more than 10% by weight of the total amount of perfluorinated polyether groups in said mixture.

Abstract: A process for reducing the level of perfluoroalkanoic acids, perfluoroalkanoic esters, and perfluoroalkyliodides in fluorinated alcohols comprising heating a fluorinated alcohol, or mixtures thereof, containing said acids, esters, or iodides to a temperature of at least 175° C. in the presence of water and a base additive is disclosed.

Abstract: This invention provides a plant growth regulatory activity of a new biologically active synthetic molecule methanone-(3?,4?,5?-trimethoxy) phenyl, 1-naphthyl, 2-O-4?-ethyl but-2?-enoate. More particularly, the invention relates to the potent plant growth promoting activity of a gallic acid derivative having a structure represented by Formula 1 and a molecular formulae C26H26O7. This invention also provides a novel process for preparation of said molecule from a naturally occurring compound and testing it for growth regulating activity using Bacopa test system developed at CIMAP (Khanuja et al.

Abstract: The present invention relates to a novel pharmaceutical composition and process for preparing swallowable methylcellulose tablets that disintegrate rapidly and meet USP disintegration standards in 0.1N hydrochloric acid as well as water.

Abstract: A composition comprising at least one G protein inhibitor of the formula wherein the substituents are defined as in the specification and the salts thereof and at least one other antihypertensive agent for the treatment of arterial hypertension.

Abstract: Neutral alpha amino diacid complexes of trace minerals and their use for animal nutrition.